Dr. Geetha Manjunath
Founder, CEO & CTO, NIRAMAI Health Analytix. On 1 show, 1 appearance. The Shows tab opens the full record on each.
founderexecutivescientistengineer@geethamhp ↗LinkedIn ↗niramai.com ↗Wikipedia ↗
Dr. Geetha Manjunath is a computer scientist and entrepreneur who founded NIRAMAI Health Analytix to develop AI-driven, non-invasive breast cancer screening technology. She previously conducted IT research for over 25 years at organizations including C-DAC, HP Labs, and Xerox India.
1shows
1appearances
17statements
13resolved
11supported
1contradicted
85%fully supported
Everything Dr. Geetha Manjunath said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Mammography fails for women under 45 due to dense breast tissue
“It does not work on women under 45 years of age because what we call as dense press, you know, The kind of fibroglandial tissue that many of the men who are like about what if I also have this and also younger women definitely have this. So, so the whole breas…”
Niramai's thermal tech works on all ages and men regardless of density
“It does work on women of all age groups because it does not depend on density. It just depends on body temperature and which all of us have similar. It does work on male as well, not just for women.”
Every clinician who tested Niramai's screening tool has purchased it
“Anyone who has tested actually sort of gone ahead and bought the solution.”
Niramai's thermal tech can be applied to detect other cancers
“It's a technology that we have developed and can be used for several other types of cancers because all other types of cancers or many, many Of those also depict a similar thermal signature that we can find too. So not just for cancer as well, this can be used…”
Mammography is the only test proven to increase survival rates
“And actually it's one of in fact, it's the only test which is proven to increase you know, increase the survival rates of women in terms of, you know, really large clinical trials and so on.”
Niramai's automated rural triage screening costs just 100 INR per test
“And so, so this, ah, is, this is almost hundred rupees per test, assuming the hardware is covered.”
Manjunath: Breast cancer kills 90,000 in India and 600,000 globally each year
“Here is a problem which is taking away 90,000 lives in India alone and more than 600,000 lives around the world when breast cancer is a completely curable type of cancer, right?”
Niramai Measures 400,000 Temperature Points Per Patient with Thermal Sensors
“So like per person, we measure 400,000. That is four lakh temperature points with these high resolution high sensitivity thermal sensors, thermal cameras.”
Niramai's hospital screening costs 1,500 INR, one-third of a mammogram
“So in a hospital, it's about one third the cost of a mammography machine, mammography tests, sorry, which basically can be around 1500 rupees in India.”
Niramai's breast cancer screening is deployed across 15 Indian cities
“So now we have it in 15 cities in India established in multiple, like Bangalore, Delhi, Chennai, Mysore, Bhuvaneswar, Dehradun, all of these places, Savopal, all of these places we do have the test available.”
Niramai Has Screened 30,000+ Women Across 70+ Hospitals
“Thankfully we do have 30,000 plus women, you know, who are able to come and stand in front of us and like take the test, you know, it's the trust of the end users and we have 70 plus hospitals who have actually fully convinced their doctors, convinced their ma…”
Niramai pitched 40 to 50 investors to raise $6M Series A
“We raised six million in this CDCA, and we and I actually met multiple investors this time, you know, many, many more investors than we met in seed round you know. 40, 50 investors, right”
Healthtech startups must validate on real patients, not lab results
“Clinical efficacy of the result is very, very important. We can't say we will do a health tech startup and go with the lab level, you know, result, you know. Trying to show this work on real patients of walking into a hospital and trying to show that your solu…”
Niramai completes ISO 13485 audit and awaits CE mark clearance
“Recently, as I mentioned, we also got an ISO 34 85 clearance, as in, we finished the audit and we're expecting the certificate at any time, and also a CE marking.”
Dr. Geetha Manjunath worked on India's first supercomputer at C-DAC
“Then I joined as one of the proud team members of the first supercomputer from India, from SIDAC, and that was my dream job.”
Manjunath: BMS Hospital became Niramai's reference customer within six months
“Within about six months or so we were able to convince a hospital to provide the solution in, their, you know, as a reference customer BMS hospital gave this as a test in their own hospital.”
One line per show, most statements first. The link opens Dr.'s full record on that show: the calibration, argument clarity, speaking style and every statement made there.
| Show | Role there | Eps | Statements | Record | |
|---|---|---|---|---|---|
 NEON SHOWLEDGER | Founder, CEO & CTO, NIRAMAI Health Analytix | 1 | 17 | 85% 11/13 | full record on the Neon Show → |